title: Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models.
authors.forename: P
authors.initials: P
authors.lastname: Vandenabeele
authors.forename: S
authors.initials: S
authors.lastname: Grootjans
authors.forename: N
authors.initials: N
authors.lastname: Callewaert
authors.forename: N
authors.initials: N
authors.lastname: Takahashi
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D004195:Disease Models, Animal; D006801:Humans; D007093:Imidazoles / Q000737:chemistry / Q000494:pharmacology*; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D007211:Indoles / Q000737:chemistry / Q000494:pharmacology*; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D051379:Mice; D053422:Receptor-Interacting Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D007093:Imidazoles; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D007211:Indoles; C507699:necrostatin-1; C506249:RIPK1 protein, human; D053422:Receptor-Interacting Protein Serine-Threonine Kinases